Global Internal Radiation Therapy Market was valued at approximately USD 1.12 billion in 2023 and is projected to expand at a compound annual growth rate (CAGR) of 6.23% from 2024 to 2032. Internal radiation therapy involves placing radioactive materials directly inside or adjacent to the tumor, delivering high doses of radiation with minimal impact on healthy tissues. This treatment modality is particularly effective for cancers such as prostate, cervical, and breast cancer. The increasing incidence of cancer worldwide, coupled with advancements in radiation technologies and growing preference for minimally invasive treatments, is driving market growth.
The Global Internal Radiation Therapy Market is driven by rising global cancer necessitating advanced treatment modalities such as brachytherapy that offer precise, localized treatment. Additionally, continuous advancements in imaging and radiation delivery technologies have significantly enhanced the efficacy and safety profiles of internal radiation therapy, further bolstering its adoption. However, the market also faces challenges, including the high costs associated with treatment, the scarcity of skilled professionals, and stringent regulatory requirements that may hinder widespread adoption.
North America holds the largest market share in 2023, supported by a well-established healthcare infrastructure, a high prevalence of cancer, and early adoption of advanced medical technologies. Europe also plays a significant role in the market, driven by substantial research and development activities and the presence of key market players. Furthermore, the Asia-Pacific region is poised to experience the fastest growth, fueled by rising cancer rates, increasing healthcare investments, and improved access to modern treatment options in countries such as China and India.
Major market players included in this report are:
Elekta AB
Varian Medical Systems, Inc.
iCAD, Inc.
Theragenics Corporation
Eckert & Ziegler BEBIG
IsoRay Medical, Inc.
C. R. Bard, Inc.
Boston Scientific Corporation
Siemens Healthineers
Becton, Dickinson and Company (BD)
Accuray Incorporated
The detailed segments and sub-segment of the market are explained below:
By Product Type:
Seeds
Applicators and Afterloaders
Electronic Internal Radiation Therapy
By Dosage Type:
High-Dose Rate (HDR) Internal Radiation Therapy
Low-Dose Rate (LDR) Internal Radiation Therapy
By Application:
Prostate Cancer
Gynecological Cancer
Breast Cancer
Other Applications
By Region:
North America
U.S.
Canada
Europe
UK
Germany
France
Spain
Italy
ROE
Asia Pacific
China
India
Japan
Australia
South Korea
RoAPAC
Latin America
Brazil
Mexico
RoLA
Middle East & Africa
Saudi Arabia
South Africa
RoMEA
Years considered for the study are as follows:
Historical year - 2022
Base year - 2023
Forecast period - 2024 to 2032
Key Takeaways:
Market Estimates & Forecast for 10 years from 2022 to 2032.
Annualized revenues and regional level analysis for each market segment.
Detailed analysis of geographical landscape with Country level analysis of major regions.
Competitive landscape with information on major players in the market.
Analysis of key business strategies and recommendations on future market approach.
Analysis of competitive structure of the market.
Demand side and supply side analysis of the market
